Krystal Biotech Inc banner

Wall St Price Targets

4KB Price Forecast
Based on 13 analysts

+33% Upside
from €272.3 today

Krystal Biotech Inc (4KB)’s 12-month stock price forecast through August 2027 has a consensus target of €363.32, implying 33% upside. The forecast is based on price targets from 13 Wall Street analysts.

4KB Analyst Rating
No ratings yet

No rating

We don't have analyst ratings for 4KB yet.

Krystal Biotech Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 4KB's stock price target?
Price Target
363.32 EUR

According to Wall Street analysts, the average 1-year price target for 4KB is 363.32 EUR with a low forecast of 255.43 EUR and a high forecast of 443.2 EUR.

What is the Revenue forecast for Krystal Biotech Inc?
Projected CAGR
22%

The compound annual growth rate for Revenue over the next 8 years is 22%.

What is the Gross Profit forecast for Krystal Biotech Inc?
Projected CAGR
22%

The compound annual growth rate for Gross Profit over the next 8 years is 22%.

What is the Operating Income forecast for Krystal Biotech Inc?
Projected CAGR
31%

The compound annual growth rate for Operating Income over the next 8 years is 31%.

What is the Pre-Tax Income forecast for Krystal Biotech Inc?
Projected CAGR
44%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.

What is the Net Income forecast for Krystal Biotech Inc?
Projected CAGR
21%

The compound annual growth rate for Net Income over the next 8 years is 21%.

Back to Top